• Info

Canticle Pharmaceuticals, Inc. SEC EDGAR Filings (CIK 0001673226)

SEC EDGAR filings, ownership reports, and insider transactions for Canticle Pharmaceuticals, Inc..

Business address
500 Office Center Drive, Suite 400, Fort Washington, PA, 19034
State of incorporation
DE
Fiscal year end
31 December
Former names
Madrigal Pharmaceuticals, Inc. (to 01 Aug 2016)
⭐ Add to watchlist ⭐
Canticle Pharmaceuticals, Inc. has filed 7 SEC EDGAR filings since 28 Apr 2016

Latest Filings

Recent SEC filings for Canticle Pharmaceuticals, Inc. including SCHEDULE 13D/A, SC 13D, D.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 12 Dec 2025 005-89582
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 12 Dec 2025 005-89582
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 01 Aug 2016 005-89582
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 01 Aug 2016 005-89582
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 29 Jul 2016 005-89582
D Open D document View SEC filing for D 28 Apr 2016 021-262200
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 28 Apr 2016

About this filer

Canticle Pharmaceuticals, Inc. files with the SEC under CIK 0001673226. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages